about
Analysis of the structure and expression of the augmenter of liver regeneration (ALR) geneAdverse effects of FK 506 overdosage after liver transplantationThe in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functionsA fresh look at augmenter of liver regeneration in ratsEffect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.Effects of rapamycin on cultured hepatocyte proliferation and gene expression.Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.Hepatotrophic effects of FK506 in dogsHepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin.Liver transplantation for type I and type IV glycogen storage disease.Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula.Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration.Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.Inhibition of liver, kidney, and intestine regeneration by rapamycinThe effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivoWeaning of immunosuppression in long-term liver transplant recipients.Liver transplantation for type IV glycogen storage diseaseCloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution.Metabolic scaling predicts posthepatectomy liver regeneration after accounting for hepatocyte hypertrophyCyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro.
P2860
Q24654809-78DC025E-9A53-4886-9625-51F21266AFECQ28367999-AB73A795-C03A-4236-84F6-D68D0E284C3BQ28574597-3468A224-2A38-4251-96EB-E1FE5C95C538Q28580301-A68AD3DA-E417-4227-A7DD-636643A5E900Q34197308-0C79CE8F-7168-458B-9CE9-3DBC80AB0CF7Q34237832-BF0BABE8-EB7B-4513-892D-214BA0EB20A5Q34240244-AFC4A2FB-41AF-4E43-8CCB-DC4FA1232575Q34240283-D778835E-56D8-4287-8F36-74058D567A7CQ34251571-D28E8873-BB28-4E4D-A9A1-E4CC2F1CAB14Q34257014-9FCFA18E-DFCB-4451-8825-C52AD64EA7E7Q34257308-0B47CC68-2438-446B-829E-06C254CC2C43Q34280991-8CF73637-DD27-4A61-8E19-1C552A828346Q34289259-EE0B62D2-EDD5-4068-AF28-133959FD7DB9Q34289587-94C54939-E6EC-4822-9BEC-67A7C1650539Q34292042-341EF7A9-1516-428A-B9F6-FDB4BA7E4EABQ34302032-06640BA1-3CFA-4ECD-A7C2-B890C09327CDQ34363624-80DFF384-5C8D-49AA-B447-DA3BE684BABEQ34421356-2140BB2F-9A85-4208-92BC-989C4D4D6BDAQ34965080-1C16F8F1-394E-45A6-ACED-31F42421B1ECQ35684766-7CCBAFAB-34B4-4FE3-85ED-D887A38ED836Q36734476-42A8B4C7-9C83-46EC-954E-8699ECB3EDC1Q42104230-9B762191-5758-4410-B8A0-5BFF02B0A2FD
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The hepatotropic influence of cyclosporine.
@ast
The hepatotropic influence of cyclosporine.
@en
The hepatotropic influence of cyclosporine.
@nl
type
label
The hepatotropic influence of cyclosporine.
@ast
The hepatotropic influence of cyclosporine.
@en
The hepatotropic influence of cyclosporine.
@nl
prefLabel
The hepatotropic influence of cyclosporine.
@ast
The hepatotropic influence of cyclosporine.
@en
The hepatotropic influence of cyclosporine.
@nl
P2093
P2860
P1433
P1476
The hepatotropic influence of cyclosporine.
@en
P2093
A Francavilla
C L Scotti-Foglieni
D H Van Thiel
K A Porter
R Venkataramanan
V Mazzaferro
P2860
P304
P407
P577
1990-05-01T00:00:00Z